Strong performance in the North American market helped drive Philips (PHG.US) Q3 comparable sales growth to 3%, surpassing expectations for adjusted EBITA.

According to the Securities Times app, Dutch medical technology company Philips (PHG.US) announced its third-quarter performance for 2025 on Tuesday. The data shows that Philips' Q3 sales declined by 2% year-on-year to 4.302 billion euros, in line with market expectations; comparable sales increased by 3%, with comparable sales in North America growing by 5%. Adjusted earnings before interest, taxes, depreciation, and amortization (EBITA) were 531 million euros, exceeding market expectations of 484 million euros. Adjusted earnings per share were 0.36 euros.